People diagnosed with breast cancer may benefit from genetic testing

If you have been diagnosed with breast cancer, genetic testing may provide the following information and benefit:

• If you have metastatic breast cancer and test positive for a BRCA mutation, you may be eligible for treatment with a targeted therapy (e.g., Lynparza or Talzenna). 
• If you have been diagnosed with earlier stage cancer, testing may effect your treatment decisions such as choice of surgery or chemotherapy, or maintenance therapy with the PARP inhibitor Lynparza.
• Test results may make you eligible for certain clinical trials and research studies.
• The test can help you understand your risk for a new cancer diagnosis and options for managing your risk.
• Test results can help your relatives understand their risk for cancer and take actions to stay healthy.